Neuraminidase 1 regulates neuropathogenesis by governing the cellular state of microglia via modulation of Trem2 sialylation
Cell Reports · 2025
DOI: 10.1016/j.celrep.2024.115204 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Leigh Ellen Fremuth und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Department of Anatomy and Neurobiology, College of Graduate He…. Hauptthemen laut MEDLINE: Receptors, Immunologic, Membrane Glycoproteins, Microglia, Neuraminidase. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Neuraminidase 1 (NEU1) cleaves terminal sialic acids from sialoglycoproteins in endolysosomes and at the plasma membrane. As such, NEU1 regulates immune cells, primarily those of the monocytic lineage. Here, we examine how Neu1 influences microglia by modulating the sialylation of full-length Trem2 (Trem2-FL), a multifunctional receptor that regulates microglial survival, phagocytosis, and cytokine production. When Neu1 is deficient/downregulated, Trem2-FL remains sialylated, accumulates intracellularly, and is excessively cleaved into a C-terminal fragment (Trem2-CTF) and an extracellular soluble domain (sTrem2), enhancing their signaling capacities. Sialylated Trem2-FL (Sia-Trem2-FL) does not hinder Trem2-FL-DAP12-Syk complex assembly but impairs signal transduction through Syk, ultimately abolishing Trem2-dependent phagocytosis. Concurrently, Trem2-CTF-DAP12 complexes dampen NF-κB signaling, while sTrem2 propagates Akt-dependent cell survival and NFAT1-mediated production of TNF-α and CCL3. Because NEU1 and Trem2 are implicated in neurodegenerative/neuroinflammatory diseases, including Alzheimer disease and sialidosis, modulating NEU1 activity represents a therapeutic approach to broadly regulate microglia-mediated neuroinflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Department of Anatomy and Neurobiology, College of Graduate Health Sciences, University of Tennessee Health Science Center, Memphis,…
- Department of Genetics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
- Department of Genetics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Compliance Office, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- NINDS NIH HHS
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke
- American Lebanese Syrian Associated Charities
- Assisi Foundation of Memphis Inc
- National Institute of General Medical Sciences
Zitieren
APA
Fremuth, L. E., Hu, H., van de Vlekkert, D., Annunziata, I., Weesner, J. A., & Alessandra d'Azzo (2025). Neuraminidase 1 regulates neuropathogenesis by governing the cellular state of microglia via modulation of Trem2 sialylation. Cell Reports. https://doi.org/10.1016/j.celrep.2024.115204
Vancouver
Fremuth LE, Hu H, van de Vlekkert D, Annunziata I, Weesner JA, Alessandra d'Azzo. Neuraminidase 1 regulates neuropathogenesis by governing the cellular state of microglia via modulation of Trem2 sialylation. Cell Reports. 2025. doi:10.1016/j.celrep.2024.115204
BibTeX
@article{Fremuth2025,
author = {Fremuth, Leigh Ellen and Hu, Huimin and van de Vlekkert, Diantha and Annunziata, Ida and Weesner, Jason Andrew and Alessandra d'Azzo},
title = {Neuraminidase 1 regulates neuropathogenesis by governing the cellular state of microglia via modulation of Trem2 sialylation},
journal = {Cell Reports},
year = {2025},
doi = {10.1016/j.celrep.2024.115204}
}
EUVIMED